期刊文献+

非小细胞肺癌姑息术后放疗108例 被引量:11

POSTOPERATIVE RADIOHERAPY FOR 108 PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) TREATED BY PALLIATIVE RESECTION
原文传递
导出
摘要 1976年1月至1986年12月,108例肺癌姑息术后,63例行术后放疗,45例对照。5年生存率术后放疗组34.9%,对照组8.8%(P<0.05)。局部复发来放疗组12.7%,对照组44%(P<0.05)。两组远地转移无差异。按临床分用、病理类型及残存部位比较,术后放疗组生存率均高于对照组。放疗剂量以50~60Gy/5~6周的5年生存率最好,为41%。 From January 1976 to December 1986,108 patients with NSCLC were treated by palliative resection of which 63 received postoperative radiation therapy and 45 who did not, served as control. The respective 5-year survival rates were 34.9% and 88%(P<0.05). The local recurrence rate was 12.7% in the combined group and 44% in the control group (P<0.05). However, the distant metastasis rates were similar in the two groups. The patients in the combined group had more advanced disease and unfarable pathology as well as site of residual lesions. Those patients who received a dose of 50-60 Gy/5-7wk gave the highest 5-year survival rate 41%.
出处 《中华放射肿瘤学杂志》 CSCD 1992年第2期18-20,68,共4页 Chinese Journal of Radiation Oncology
  • 相关文献

参考文献7

  • 1金性江,吴湘玮,胡自省.非小细胞肺癌术后放疗的价值——附268例报告[J].中华放射肿瘤学杂志,1990,0(3):31-32. 被引量:4
  • 2杨雁飞,崔守仁.肺癌术后放疗的评价[J].中华放射肿瘤学杂志,1989(3):14-15. 被引量:3
  • 3Noah C.Controversies in the role of postoperative radiotherapy in stages Ⅱ and Ⅲa resected non-small cell lung carcinoma. International Journal of Radiation Oncology Biology Physics . 1991
  • 4Chung MD.Evaluation of adjuvant postoperative radiotherapy for lung cancer. International Journal of Radiation Oncology Biology Physics . 1982
  • 5Clemente I.local Recurrence of resectable non-oat cell carcinoma or the lung. Cancer . 1986
  • 6Belcher JR.Thirty years of surgery for carcinoma of bronchus. Thorax . 1983
  • 7Jerry D.Radiation therapy following resection of non small cell lung cancer. International Journal of Radiation Oncology Biology Physics . 1991

二级参考文献1

  • 1吴怀申,王吉民.肺癌侵犯胸壁的外科治疗和预后[J]癌症,1985(02).

共引文献5

同被引文献50

  • 1于楠 王金柱 等.老年肺癌病理分型及外科治疗[J].天津医药,1986,11:646-646.
  • 2[1]Mountain CF.A new international staging system for lung cancer[J].Chest,1986,89(suppl):225.
  • 3[4]Douillard JY,Delena M.ANITA:Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts):Final results after 70-month median follow-up.On behalf of the Adjuvant Navelbine International Trialist Association[J].J Clin Oncol,2005,23(16s):7013.
  • 4[5]Rao J,Sayeed RA,Tomaszek S,et al.Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer[J].Ann Thorac Surg,2007 Sep,84(3):934-938.
  • 5[6]Macchiarini P,Chapelier AR,Monnort I,et al.Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer[J].Ann Thorac Surg,1994,57:966.
  • 6[7]Albain KS,Rusch VW,Crowley JJ,et al.Concurrent cisplatin/etoposide plus chest radiation therapy followed by surgery for stage IIIA (N2) and IIIB non-small cell lung cancer:mature results of Southwest Oncology Group Phase II Study 8805[J].J Clin Oncol,1995,13:1880-1892.
  • 7[8]Misthos P,Papagiannakis G,Kokotsakis J,et al.Surgical management of lung cancer invading the aorta or the superior vena cava[J].Lung Cancer,2007,56(2):223-237.
  • 8[9]Zell JA,Ou SH,Ziogas A,et al.Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules[J].Cancer,2007,25:136-143.
  • 9[10]Nagai K,Sohara Y,Tsuchiya R,et al.Prognosis of resected non-small cell lung cancer patients with intrapulmonary metastases[J].J Thorac Oncol,2007,2(4):282-286.
  • 10[1]Heny wagner Jr. Radiation therapy in the management of patients with unresectable stage Ⅲ A and Ⅲ B non-small cell lung cancer [J].Seminars in Oncology, 1997, 24 (4): 423 - 428.

引证文献11

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部